{
    "clinical_study": {
        "@rank": "63733", 
        "acronym": "DIAPASON", 
        "arm_group": [
            {
                "arm_group_label": "Patients with type II diabetes", 
                "arm_group_type": "Experimental", 
                "description": "Type II diabetes patients with aortic valve stenosis referred for aortic valve replacement."
            }, 
            {
                "arm_group_label": "Patients without type II diabetes", 
                "arm_group_type": "Experimental", 
                "description": "No type II diabetes patients with aortic valve stenosis referred for aortic valve replacement."
            }
        ], 
        "brief_summary": {
            "textblock": "This project focuses on the physiopathology of  left ventricular remodeling associated with\n      type II diabetes in patients with aortic valve stenosis referred for surgical aortic valve\n      replacement.\n\n      The main objective is to compare the reverse left ventricular remodeling between patients\n      with type II diabetes and case-control patients without diabetes at one(1) year after\n      surgical aortic valve replacement.\n\n      The secondary objectives are :\n\n        1. assess the influence of type II diabetes on left ventricular remodeling in patients\n           presenting with aortic valve stenosis,\n\n        2. assess the predictive value of myocardial fibrosis and other LV characteristics present\n           prior to aortic valve surgery on the LV reverse remodeling and their influence on\n           cardiovascular events at one (1) year after surgery,\n\n        3. assess the influence of type II diabetes on cardiovascular morbidity and mortality post\n           aortic valve surgery.\n\n      The investigators main hypothesis is that patients with type II diabetes and aortic valve\n      stenosis requiring aortic valve replacement have poorer LV function and  less favorable post\n      surgery clinical outcomes than patients without type II diabetes."
        }, 
        "brief_title": "Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Replacement Surgery.", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Type II Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Aortic Valve Stenosis", 
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Ventricular Remodeling"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years\n\n          -  BMI < 30 kg/m2\n\n          -  Arm 1: Treated Type II diabetes, Arm 2: absence of type II diabetes\n\n          -  Aortic valve stenosis\n\n          -  LVEF > 55% with no kinetic abnormalities\n\n          -  Non significant obstructive coronary artery disease\n\n          -  Absence of gadolinium enhanced MRI contraindications\n\n          -  Informed consent signed\n\n          -  Patient affiliated to the French Social Security.\n\n        Exclusion Criteria:\n\n          -  Chronic arrhythmia or absence of sinus rhythm\n\n          -  Past history of cardiomyopathy or coronary insufficiency\n\n          -  Significant coronaropathy seen during the coronary angiography with >50% degree\n             stenosis prior to aortic valve replacement\n\n          -  Hemodynamically significant valvular dysfunction other than aortic stenosis (grade 2\n             mitral or aortic insufficiency, mitral valve stenosis < 1.5 cm2\n\n          -  Systemic chronic inflammatory disease leading to cardiac injury (scleroderma)\n\n          -  Renal insufficiency (clearance < 30 ml/min)\n\n          -  Insufficient transthoracic echocardiography echogenicity\n\n          -  Type I diabetes mellitus\n\n          -  Uncontrolled hypertension (> 160/100 mm Hg)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01862237", 
            "org_study_id": "2011.699"
        }, 
        "intervention": {
            "arm_group_label": [
                "Patients with type II diabetes", 
                "Patients without type II diabetes"
            ], 
            "description": "blood collection\nCompletion of a pre-operative cardiac MRI.\nCompletion of a coronary angiography examination\nCompletion  during the surgery d'une myocardial biopsy,\nAortic echocardiographic follow-up (including post-operative ultrasound and ultrasound at 1 year\nCompletion of a cardiac MRI 1 year after surgery.", 
            "intervention_name": "Intervention", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Type II diabetes", 
            "aortic valve stenosis", 
            "left ventricular remodeling", 
            "aortic valve replacement surgery"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "contact": {
                "email": "helene.thibault@chu-lyon.fr", 
                "last_name": "H\u00e9l\u00e8ne THIBAULT", 
                "phone": "4 72 35 73 32", 
                "phone_ext": "+33"
            }, 
            "facility": {
                "address": {
                    "city": "Lyon", 
                    "country": "France"
                }, 
                "name": "Hospices Civils de Lyon - H\u00f4pital Louis Pradel"
            }, 
            "investigator": {
                "last_name": "H\u00e9l\u00e8ne THIBAULT", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Does Type II Diabetes Influence Prognosis and Left Ventricular Remodeling in Patients With Aortic Valve Stenosis Referred for Aortic Valve Replacement ?", 
        "overall_contact": {
            "email": "helene.thibault@chu-lyon.fr", 
            "last_name": "H\u00e9l\u00e8ne THIBAULT", 
            "phone": "4 72 35 73 32", 
            "phone_ext": "+33"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Left Ventricular Mass measured by echocardiography", 
            "safety_issue": "No", 
            "time_frame": "Primary outcome is assessed at one year 1 year after aortic valve replacement."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01862237"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "cardiovascular events (cardiac mortality, heart failure, atrial or ventricular rhythm abnormalities) and clinical improvement (NYHA class, 6-minute walk test).", 
                "safety_issue": "No", 
                "time_frame": "1 year after aortic valve replacement."
            }, 
            {
                "measure": "Measurement of BNP (Brain Natriuretic Peptide).", 
                "safety_issue": "No", 
                "time_frame": "1 year after aortic valve replacement."
            }, 
            {
                "description": "Left Ventricular Ejection Fraction, Systolic Longitudinal Strain, Systolic Circumferential Strain, Systolic Radial Strain, Diameters, wall thickness.", 
                "measure": "Echocardiographic parameters.", 
                "safety_issue": "No", 
                "time_frame": "1 year after aortic valve replacement."
            }, 
            {
                "description": "LV mass, volumes, ejection fraction, replacement fibrosis mass on delayed enhanced studies,  and interstitial fibrosis quantification (T1 mapping studies).", 
                "measure": "Magnetic Resonance Imaging (MRI) parameters.", 
                "safety_issue": "No", 
                "time_frame": "1 year after aortic valve replacement."
            }
        ], 
        "source": "Hospices Civils de Lyon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospices Civils de Lyon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}